Why More Data Makes Diligence Worse

Comprehensive due diligence reports have grown longer while deal timelines have grown shorter. The mismatch creates predictable problems: critical findings appear where time-pressured readers don't reach them.

Two forces drive this pattern. Buyers equate report length with thoroughness, creating market demand for comprehensive scope. Providers face liability exposure if they miss something, creating incentive to include everything defensible rather than filter for what matters most. The result serves neither party well.

Comprehensive reports signal effort. A 287-page document suggests the provider looked everywhere, asked every question, checked every box. For buyers under pressure to justify decisions to LPs or boards, the heft provides comfort. The due diligence was thorough because the report is comprehensive.

This reasoning confuses input with output. A comprehensive report documents what was examined, not what was concluded. It proves scope, not judgment. But in high-stakes decisions with limited review time, buyers rely on proxy signals. Report length becomes a proxy for analytical rigor.

The market reinforces this dynamic. Buyers request comprehensive scope in RFPs. Providers compete on breadth of coverage. Reports grow longer to demonstrate completeness. Buyers receive what they asked for: documentation of thoroughness, structured to protect against the question "did you check X?" rather than to answer "should we proceed?"

What gets lost is the analytical layer. Where comprehensive reports excel at describing what exists, they often fail at interpreting what it means. A finding appears on page 203, surrounded by 50 other findings of varying significance, with no explicit hierarchy or confidence level. The reader must supply the judgment the report declines to provide.

Due diligence providers face asymmetric risk. If a deal fails because of something the report mentioned on page 247, the provider can point to disclosure. If a deal fails because the report never mentioned it, the provider faces liability exposure and reputation damage. The rational response is comprehensive inclusion.

Professional indemnity insurance requirements reinforce this behavior. Insurers evaluate DD firms on documentation practices and scope coverage. Claims history matters. A missed finding that was never investigated creates liability exposure. A missed finding that was documented somewhere in the deliverable does not. The incentive structure rewards comprehensive documentation over diagnostic clarity.

The repeat business dynamic adds another layer. DD providers depend on recurring clients. A report that kills a deal the buyer wanted to pursue creates friction. A comprehensive report that presents findings without explicit severity ranking allows the buyer to weigh the information and reach their own conclusion. The provider can point to thoroughness without taking positions that might cost them the next engagement.

The result is predictable: reports optimized for defensibility rather than decision-making. Every potentially relevant finding gets included, documented with appropriate caveats, and placed in the comprehensive flow. If questioned later, the provider can demonstrate they found it, disclosed it, and documented it. Whether the buyer actually saw it in their 47-minute review becomes the buyer's problem.

Reports have grown substantially longer. Mid-market PE deals that once received 120-150 page reports now routinely get 250-300 pages. This pattern extends beyond due diligence: research shows median 10-K filings doubled from 23,000 words in 1996 to 50,000 words in 2013, while Ernst & Young found 10-K disclosures quadrupled over 20 years. The scope hasn't changed proportionally; the documentation standard has.

Reading time reality compounds the problem. At average adult reading pace (238 words per minute for non-fiction), a 287-page report with typical density (500 words per page) requires approximately 10 hours of sustained focus. Even high-level executives who read at 500 wpm would need nearly 5 hours. Deal timelines rarely accommodate either. Investment committee meetings operate on partner review of executive summaries and selective deep-dives into flagged issues, not sustained multi-hour document analysis.

In our experience inheriting prior DD work, a consistent pattern emerges: material findings that prior providers flagged as significant regularly appear deep in comprehensive reports, often beyond page 100, where time-pressured executive review rarely reaches in deal timelines. These are not incidental findings buried in appendices; they are items the provider explicitly identified as material but positioned where they're unlikely to influence decision-making.

Red Label regularly inherits prior DD work when deals proceed to advanced stages or when buyers seek second opinions on troubled portfolio companies. The pattern is consistent: comprehensive reports that documented relevant issues without surfacing them effectively. The information was present; the diagnostic assessment was absent or diffused across hundreds of pages of qualified observations.

Comprehensive documentation serves legitimate purposes. Tax advisors need detailed analysis of entity structures and historical filings. Environmental consultants need site-specific data and regulatory compliance history. Legal teams need thorough contract review and litigation analysis. For specialists working in their domains, depth and detail are essential.

The question becomes one of report architecture rather than content scope. Comprehensive appendices and specialist sections can coexist with diagnostic executive summaries. The problem emerges when providers apply the comprehensive approach to the executive layer, where strategic decision-makers need synthesis and judgment rather than exhaustive documentation.

Some deals genuinely require extensive documentation: cross-border transactions with multi-jurisdictional regulatory complexity, distressed situations with litigation exposure, or highly technical sectors where specialist assessment drives valuation. The issue is not that comprehensive reports never have value; it's that providers default to maximum scope regardless of deal complexity, and structure reports for defensibility rather than decision support.

The distinction matters. Comprehensive technical appendices that support specialist work are valuable and appropriate. Comprehensive findings that bury material issues in undifferentiated executive flow serve neither analytical nor defensive purposes well. The former preserves depth where needed; the latter creates noise that obscures signal.

Red Label structures reports around explicit severity ratings and confidence levels. Every material finding receives a confidence assessment (High/Medium/Low) that reflects source quality, corroboration, and analytical certainty. Findings get ranked by potential deal impact, not by categorical placement or alphabetical order. This forces analytical discipline: the provider must take positions rather than hide behind comprehensive disclosure.

The report architecture inverts traditional flow. The executive summary leads with diagnostic assessment: what matters most, why it matters, and how confident we are in that judgment. Material findings appear first, with explicit severity ratings and clear implications for deal decisions. Comprehensive detail and specialist analysis populate appendices that support but don't obstruct the diagnostic layer.

This approach answers a different question than comprehensive reports. Where traditional DD documents scope coverage ("we examined X, Y, and Z"), diagnostic reports answer decision relevance ("here's what matters, here's why, and here's how certain we are"). The comprehensive research still happens; it simply doesn't drive report structure or obscure analytical conclusions.

Taking explicit positions requires professional courage that comprehensive scope lets providers avoid. Saying "High confidence that regulatory compliance poses material deal risk" is different from documenting compliance issues on page 203 alongside 47 other findings. The former requires judgment and creates accountability; the latter provides coverage without commitment. The diagnostic approach accepts that accountability as the core value proposition.

Consider a management team assessment finding. The information is identical; the presentation determines whether it influences the decision.

The traditional approach documents the information accurately but leaves interpretation to the reader, positioned where time pressure makes discovery unlikely. The diagnostic approach forces explicit judgment, positions it for visibility, and provides actionable implications. Both approaches document the same facts; one structures for decision support, the other for defensibility.

The diagnostic approach does not reduce research scope or effort. Red Label's comprehensive research often matches or exceeds traditional providers in breadth and depth. The difference lies in report architecture and analytical discipline. Every finding that would appear in a comprehensive report still gets investigated and documented; it simply doesn't all appear in the executive flow unless it meets materiality and relevance thresholds.

Buyers accustomed to comprehensive reports sometimes resist diagnostic structure initially. The shorter executive summary and explicit severity ratings feel different from what they've received before. But decision-makers consistently report that diagnostic reports improve their ability to make informed decisions under time pressure. The cognitive load decreases; the analytical clarity increases.

The diagnostic approach requires more analytical discipline from providers than comprehensive documentation. It's harder to write "High confidence this matters" than to write "we observed this." The former requires judgment, interpretation, and accountability; the latter requires only accurate documentation. This explains why many providers default to comprehensive scope: it's defensible with less analytical risk.

Some traditional providers are experimenting with executive summary enhancements and severity flagging systems. AI-powered tools are emerging that promise to summarize lengthy reports and surface key findings through natural language queries. These modifications acknowledge the volume problem while preserving comprehensive core structure. Whether technological solutions or incremental process changes address the fundamental incentive misalignment between buyer decision needs and provider liability concerns remains to be tested by market selection over time. Technology can accelerate document processing, but it cannot substitute for the analytical judgment required to determine what matters most in a specific deal context.

More data can make diligence worse when report architecture buries signal in noise and provider incentives optimize for defensibility rather than decision clarity. This is not a failure of individual firms or practitioners; it's a systems problem driven by liability exposure, market expectations, and professional insurance requirements. The issue is not volume itself, but how that volume is structured and presented to decision-makers operating under time constraints.

Buyers can continue requesting comprehensive scope and accepting the volume-clarity tradeoff, treating DD reports as documentation to support decisions reached through other means. Or buyers can prioritize diagnostic assessment and explicit analytical positions, accepting that shorter executive summaries with clear severity ratings require providers to take positions that create accountability.

Red Label's approach reflects a judgment about what due diligence should accomplish: not comprehensive documentation that protects providers, but diagnostic assessment that supports decisions. This requires accepting analytical accountability that comprehensive scope lets firms avoid. The market will determine whether buyers value that clarity enough to reward providers who accept that risk.